Higher Uveitis Risk in Cancer Patients on BRAF Inhibitors
BRAF inhibitors raise the risk for uveitis in patients with skin melanoma or lung cancer compared with conventional cytotoxic drugs or immune checkpoint inhibitors.
Medscape Medical News
source https://www.medscape.com/viewarticle/higher-uveitis-risk-patients-cancer-braf-inhibitors-2024a1000ekr?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/higher-uveitis-risk-patients-cancer-braf-inhibitors-2024a1000ekr?src=rss
Comments
Post a Comment